參考文獻 |
Aboussekhra, A. and Wood, R.D. (1995) Detection of nucleotide excision repair incisions in human fibroblasts by immunostaining for PCNA. Exp Cell Res, 221, 326-32.
Angelastro, J.M., Klimaschewski, L.P. and Vitolo, O.V. (2000) Improved NlaIII digestion of PAGE-purified 102 bp ditags by addition of a single purification step in both the SAGE and microSAGE protocols [In Process Citation]. Nucleic Acids Res, 28, E62.
Ashcroft, M. and Vousden, K.H. (1999) Regulation of p53 stability. Oncogene, 18, 7637-43.
Ashkenazi, A. and Dixit, V.M. (1998) Death receptors: signaling and modulation. Science, 281, 1305-8.
Bargonetti, J., Manfredi, J.J., Chen, X., Marshak, D.R. and Prives, C. (1993) A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein. Genes Dev, 7, 2565-74.
Birkenbihl, R.P. and Subramani, S. (1995) The rad21 gene product of Schizosaccharomyces pombe is a nuclear, cell cycle-regulated phosphoprotein. J Biol Chem, 270, 7703-11.
Bittner, M., Meltzer, P. and Trent, J. (1999) Data analysis and integration: of steps and arrows [news; comment] [see comments]. Nat Genet, 22, 213-5.
Bravo, R., Frank, R., Blundell, P.A. and Macdonald Bravo, H. (1987) Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature, 326, 515-7.
Brown, K.D., Lataxes, T.A., Shangary, S., Mannino, J.L., Giardina, J.F., Chen, J. and Baskaran, R. (2000) Ionizing radiation exposure results in up-regulation of Ku70 via a p53/ataxia-telangiectasia-mutated protein-dependent mechanism. J Biol Chem, 275, 6651-6.
Burns, T.F. and El Deiry, W.S. (1999) The p53 pathway and apoptosis. J Cell Physiol, 181, 231-9.
Carulli, J.P., Artinger, M., Swain, P.M., Root, C.D., Chee, L., Tulig, C., Guerin, J., Osborne, M., Stein, G., Lian, J. and Lomedico, P.T. (1998) High throughput analysis of differential gene expression. J Cell Biochem Suppl, 30-31, 286-96.
Chen, J.J., Wu, R., Yang, P.C., Huang, J.Y., Sher, Y.P., Han, M.H., Kao, W.C., Lee, P.J., Chiu, T.F., Chang, F., Chu, Y.W., Wu, C.W. and Peck, K. (1998) Profiling expression patterns and isolating differentially expressed genes by cDNA microarray system with colorimetry detection. Genomics, 51, 313-24.
Chen, J.Y., Funk, W.D., Wright, W.E., Shay, J.W. and Minna, J.D. (1993) Heterogeneity of transcriptional activity of mutant p53 proteins and p53 DNA target sequences. Oncogene, 8, 2159-66.
Chen, P.L., Chen, Y.M., Bookstein, R. and Lee, W.H. (1990) Genetic mechanisms of tumor suppression by the human p53 gene. Science, 250, 1576-80.
Clore, G.M., Omichinski, J.G., Sakaguchi, K., Zambrano, N., Sakamoto, H., Appella, E. and Gronenborn, A.M. (1994) High-resolution structure of the oligomerization domain of p53 by multidimensional NMR [see comments] [published erratum appears in Science 1995 Mar 10;267(5203):1515]. Science, 265, 386-91.
Cochran, R. and Rosen, T. (1983) African trypanosomiasis in the United States. Arch Dermatol, 119, 670-4.
Cross, S.M., Sanchez, C.A., Morgan, C.A., Schimke, M.K., Ramel, S., Idzerda, R.L., Raskind, W.H. and Reid, B.J. (1995) A p53-dependent mouse spindle checkpoint. Science, 267, 1353-6.
Dang, C.V. and Lee, W.M. (1989) Nuclear and nucleolar targeting sequences of c-erb-A, c-myb, N-myc, p53, HSP70, and HIV tat proteins. J Biol Chem, 264, 18019-23.
Difilippantonio, M.J., Zhu, J., Chen, H.T., Meffre, E., Nussenzweig, M.C., Max, E.E., Ried, T. and Nussenzweig, A. (2000) DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature, 404, 510-4.
Duggan, D.J., Bittner, M., Chen, Y., Meltzer, P. and Trent, J.M. (1999) Expression profiling using cDNA microarrays. Nat Genet, 21, 10-4.
El-Deiry, W.S. (1998) Regulation of p53 downstream genes. Semin Cancer Biol, 8, 345-57.
El-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W. and Vogelstein, B. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817-25.
Eliyahu, D., Michalovitz, D., Eliyahu, S., Pinhasi-Kimhi, O. and Oren, M. (1989) Wild-type p53 can inhibit oncogene-mediated focus formation. Proc Natl Acad Sci U S A, 86, 8763-7.
Finnie, C., Borch, J. and Collinge, D.B. (1999) 14-3-3 proteins: eukaryotic regulatory proteins with many functions. Plant Mol Biol, 40, 545-54.
Fuchs, S.Y., Adler, V., Pincus, M.R. and Ronai, Z. (1998) MEKK1/JNK signaling stabilizes and activates p53. Proc Natl Acad Sci U S A, 95, 10541-6.
Gaiddon, C., Moorthy, N.C. and Prives, C. (1999) Ref-1 regulates the transactivation and pro-apoptotic functions of p53 in vivo. EMBO J, 18, 5609-21.
Gallouzi, I.E., Parker, F., Chebli, K., Maurier, F., Labourier, E., Barlat, I., Capony, J.P., Tocque, B. and Tazi, J. (1998) A novel phosphorylation-dependent RNase activity of GAP-SH3 binding protein: a potential link between signal transduction and RNA stability. Mol Cell Biol, 18, 3956-65.
Gottlieb, T.M. and Oren, M. (1998) p53 and apoptosis. Semin Cancer Biol, 8, 359-68.
Greenblatt, M.S., Bennett, W.P., Hollstein, M. and Harris, C.C. (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res, 54, 4855-78.
Gu, W. and Roeder, R.G. (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell, 90, 595-606.
Hermeking, H., Lengauer, C., Polyak, K., He, T.C., Zhang, L., Thiagalingam, S., Kinzler, K.W. and Vogelstein, B. (1997) 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell, 1, 3-11.
Hollstein, M., Rice, K., Greenblatt, M.S., Soussi, T., Fuchs, R., Sorlie, T., Hovig, E., Smith Sorensen, B., Montesano, R. and Harris, C.C. (1994) Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res, 22, 3551-5.
Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C.C. (1991) p53 mutations in human cancers. Science, 253, 49-53.
Hupp, T.R. and Lane, D.P. (1995) Two distinct signaling pathways activate the latent DNA binding function of p53 in a casein kinase II-independent manner. J Biol Chem, 270, 18165-74.
Israeli, D., Tessler, E., Haupt, Y., Elkeles, A., Wilder, S., Amson, R., Telerman, A. and Oren, M. (1997) A novel p53-inducible gene, PAG608, encodes a nuclear zinc finger protein whose overexpression promotes apoptosis. EMBO J, 16, 4384-92.
Jayaraman, L., Murthy, K.G., Zhu, C., Curran, T., Xanthoudakis, S. and Prives, C. (1997) Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev, 11, 558-70.
Jeffrey, P.D., Gorina, S. and Pavletich, N.P. (1995) Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms. Science, 267, 1498-502.
Jenkins, J.R., Rudge, K., Chumakov, P. and Currie, G.A. (1985) The cellular oncogene p53 can be activated by mutagenesis. Nature, 317, 816-8.
Jenkins, J.R., Rudge, K. and Currie, G.A. (1984) Cellular immortalization by a cDNA clone encoding the transformation- associated phosphoprotein p53. Nature, 312, 651-4.
Johnson, R.E., Kovvali, G.K., Guzder, S.N., Amin, N.S., Holm, C., Habraken, Y., Sung, P., Prakash, L. and Prakash, S. (1996) Evidence for involvement of yeast proliferating cell nuclear antigen in DNA mismatch repair. J Biol Chem, 271, 27987-90.
Jongmans, W., Artuso, M., Vuillaume, M., Bresil, H., Jackson, S.P. and Hall, J. (1996) The role of Ataxia telangiectasia and the DNA-dependent protein kinase in the p53-mediated cellular response to ionising radiation. Oncogene, 13, 1133-8.
Kamijo, T., Weber, J.D., Zambetti, G., Zindy, F., Roussel, M.F. and Sherr, C.J. (1998) Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc Natl Acad Sci U S A, 95, 8292-7.
Koyama, S., Williams, L.T. and Kikuchi, A. (1995) Characterization of the interaction of Raf-1 with ras p21 or 14-3-3 protein in intact cells. FEBS Lett, 368, 321-5.
Lane, D.P. (1992) Cancer. p53, guardian of the genome [news; comment] [see comments]. Nature, 358, 15-6.
Lane, D.P. and Crawford, L.V. (1979) T antigen is bound to a host protein in SV40-transformed cells. Nature, 278, 261-3.
Lee, S., Elenbaas, B., Levine, A. and Griffith, J. (1995) p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell, 81, 1013-20.
Levine, A.J. (1997) p53, the cellular gatekeeper for growth and division. Cell, 88, 323-31.
Lill, N.L., Grossman, S.R., Ginsberg, D., DeCaprio, J. and Livingston, D.M. (1997) Binding and modulation of p53 by p300/CBP coactivators. Nature, 387, 823-7.
Lu, H. and Levine, A.J. (1995) Human TAFII31 protein is a transcriptional coactivator of the p53 protein. Proc Natl Acad Sci U S A, 92, 5154-8.
Lu, X. and Lane, D.P. (1993) Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes? Cell, 75, 765-78.
Marx, J. (1994) New link found between p53 and DNA repair [news; comment]. Science, 266, 1321-2.
Masuda, Y., Bennett, R.A. and Demple, B. (1998) Dynamics of the interaction of human apurinic endonuclease (Ape1) with its substrate and product. J Biol Chem, 273, 30352-9.
May, P. and May, E. (1999) Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene, 18, 7621-36.
McKay, M.J., Troelstra, C., van der Spek, P., Kanaar, R., Smit, B., Hagemeijer, A., Bootsma, D. and Hoeijmakers, J.H. (1996) Sequence conservation of the rad21 Schizosaccharomyces pombe DNA double-strand break repair gene in human and mouse. Genomics, 36, 305-15.
Michalovitz, D., Halevy, O. and Oren, M. (1990) Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell, 62, 671-80.
Midgley, C.A. and Lane, D.P. (1997) p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding. Oncogene, 15, 1179-89.
Milczarek, G.J., Martinez, J. and Bowden, G.T. (1997) p53 Phosphorylation: biochemical and functional consequences. Life Sci, 60, 1-11.
Milne, D.M., Campbell, D.G., Caudwell, F.B. and Meek, D.W. (1994) Phosphorylation of the tumor suppressor protein p53 by mitogen-activated protein kinases. J Biol Chem, 269, 9253-60.
Mils, V., Baldin, V., Goubin, F., Pinta, I., Papin, C., Waye, M., Eychene, A. and Ducommun, B. (2000) Specific interaction between 14-3-3 isoforms and the human CDC25B phosphatase. Oncogene, 19, 1257-65.
Morris, G.F., Bischoff, J.R. and Mathews, M.B. (1996) Transcriptional activation of the human proliferating-cell nuclear antigen promoter by p53. Proc Natl Acad Sci U S A, 93, 895-9.
Mummenbrauer, T., Janus, F., Muller, B., Wiesmuller, L., Deppert, W. and Grosse, F. (1996) p53 Protein exhibits 3'-to-5' exonuclease activity. Cell, 85, 1089-99.
Okamura, S., Ng, C.C., Koyama, K., Takei, Y., Arakawa, H., Monden, M. and Nakamura, Y. (1999) Identification of seven genes regulated by wild-type p53 in a colon cancer cell line carrying a well-controlled wild-type p53 expression system. Oncol Res, 11, 281-5.
Pamer, E. and Cresswell, P. (1998) Mechanisms of MHC class I--restricted antigen processing. Annu Rev Immunol, 16, 323-58.
Parada, L.F., Land, H., Weinberg, R.A., Wolf, D. and Rotter, V. (1984) Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation. Nature, 312, 649-51.
Paulus, C.J., HOEVEN1, J.C.M., WAL, P.R., Marc C. M., DIJK, Wim, J. and BLITTERSWIJK2. (2000) 14-3-3 Isotypes facilitate coupling of protein kinase C- z to Raf-1: negative regulation by 14-3-3 phosphorylation. Biochem. J, 345, 297-306.
Pietenpol, J.A., Tokino, T., Thiagalingam, S., el Deiry, W.S., Kinzler, K.W. and Vogelstein, B. (1994) Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc Natl Acad Sci U S A, 91, 1998-2002.
Polyak, K., Xia, Y., Zweier, J.L., Kinzler, K.W. and Vogelstein, B. (1997) A model for p53-induced apoptosis [see comments]. Nature, 389, 300-5.
Ponka, P., Beaumont, C. and Richardson, D.R. (1998) Function and regulation of transferrin and ferritin. Semin Hematol, 35, 35-54.
Ponka, P. and Lok, C.N. (1999) The transferrin receptor: role in health and disease. Int J Biochem Cell Biol, 31, 1111-37.
Prives, C. and Hall, P.A. (1999) The p53 pathway. J Pathol, 187, 112-26.
Rajah, R., Valentinis, B. and Cohen, P. (1997) Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism. J Biol Chem, 272, 12181-8.
Rotter, V., Aloni Grinstein, R., Schwartz, D., Elkind, N.B., Simons, A., Wolkowicz, R., Lavigne, M., Beserman, P., Kapon, A. and Goldfinger, N. (1994) Does wild-type p53 play a role in normal cell differentiation? Semin Cancer Biol, 5, 229-36.
Sakaguchi, K., Herrera, J.E., Saito, S., Miki, T., Bustin, M., Vassilev, A., Anderson, C.W. and Appella, E. (1998) DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev, 12, 2831-41.
Sakamuro, D., Sabbatini, P., White, E. and Prendergast, G.C. (1997) The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene, 15, 887-98.
Schena, M., Shalon, D., Davis, R.W. and Brown, P.O. (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray [see comments]. Science, 270, 467-70.
Sheikh, M.S. and Fornace, A.J., Jr. (2000) Role of p53 family members in apoptosis. J Cell Physiol, 182, 171-81.
Shieh, S.Y., Ikeda, M., Taya, Y. and Prives, C. (1997) DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell, 91, 325-34.
Shivji, K.K., Kenny, M.K. and Wood, R.D. (1992) Proliferating cell nuclear antigen is required for DNA excision repair. Cell, 69, 367-74.
Siliciano, J.D., Canman, C.E., Taya, Y., Sakaguchi, K., Appella, E. and Kastan, M.B. (1997) DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev, 11, 3471-81.
Smith, M.L., Chen, I.T., Zhan, Q., Bae, I., Chen, C.Y., Gilmer, T.M., Kastan, M.B., O'Connor, P.M. and Fornace, A.J., Jr. (1994) Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen [see comments]. Science, 266, 1376-80.
Soussi, T. and May, P. (1996) Structural aspects of the p53 protein in relation to gene evolution: a second look. J Mol Biol, 260, 623-37.
Stillman, B. (1994) Initiation of chromosomal DNA replication in eukaryotes. Lessons from lambda. J Biol Chem, 269, 7047-50.
Takekawa, M., Posas, F. and Saito, H. (1997) A human homolog of the yeast Ssk2/Ssk22 MAP kinase kinase kinases, MTK1, mediates stress-induced activation of the p38 and JNK pathways. EMBO J, 16, 4973-82.
Tamayo, P., Slonim, D., Mesirov, J., Zhu, Q., Kitareewan, S., Dmitrovsky, E., Lander, E.S. and Golub, T.R. (1999) Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc Natl Acad Sci U S A, 96, 2907-12.
Tatebayashi, K., Kato, J. and Ikeda, H. (1998) Isolation of a Schizosaccharomyces pombe rad21ts mutant that is aberrant in chromosome segregation, microtubule function, DNA repair and sensitive to hydroxyurea: possible involvement of Rad21 in ubiquitin-mediated proteolysis. Genetics, 148, 49-57.
Thut, C.J., Chen, J.L., Klemm, R. and Tjian, R. (1995) p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60. Science, 267, 100-4.
Toschi, L. and Bravo, R. (1988) Changes in cyclin/proliferating cell nuclear antigen distribution during DNA repair synthesis. J Cell Biol, 107, 1623-8.
Tuteja, R. and Tuteja, N. (2000) Ku autoantigen: a multifunctional DNA-binding protein. Crit Rev Biochem Mol Biol, 35, 1-33.
Unger, T., Sionov, R.V., Moallem, E., Yee, C.L., Howley, P.M., Oren, M. and Haupt, Y. (1999) Mutations in serines 15 and 20 of human p53 impair its apoptotic activity. Oncogene, 18, 3205-12.
Walker, K.K. and Levine, A.J. (1996) Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc Natl Acad Sci U S A, 93, 15335-40.
Waterman, M.J., Stavridi, E.S., Waterman, J.L. and Halazonetis, T.D. (1998) ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nat Genet, 19, 175-8.
Whitney, J.F., Clark, J.M., Griffin, T.W., Gautam, S. and Leslie, K.O. (1995) Transferrin receptor expression in nonsmall cell lung cancer. Histopathologic and clinical correlates [see comments]. Cancer, 76, 20-5.
Xing, H., Zhang, S., Weinheimer, C., Kovacs, A. and Muslin, A.J. (2000) 14-3-3 proteins block apoptosis and differentially regulate MAPK cascades. EMBO J, 19, 349-58.
Zamzami, N., Brenner, C., Marzo, I., Susin, S.A. and Kroemer, G. (1998) Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins. Oncogene, 16, 2265-82.
Zhu, K., Wang, J., Zhu, J., Jiang, J., Shou, J. and Chen, X. (1999) p53 induces TAP1 and enhances the transport of MHC class I peptides. Oncogene, 18, 7740-7. |